Expanding access to vaccines, contraceptives, and diagnostics for home and abroad
With its huge population and economic diversity, China experiences a wide range of health issues. And because of its tremendous growth and resources, it is also well positioned to develop affordable, accessible, and sustainable health solutions that can be exported to other nations in need.
Since 1979, PATH has collaborated with Chinese government agencies, research institutes, nongovernmental organizations, and manufacturers to address the country’s health needs and build its capacity to contribute to global health. Our public-private partnership model for developing health products has been key to our success.
Our work in China
Vaccines and immunization: A key focus of our work is partnering with Chinese manufacturers to develop and produce low-cost, high-quality vaccines. PATH has worked with our Chinese manufacturing partner, Chengdu Institute of Biological Products Co., Ltd., since 2006 to bring an effective and affordable vaccine against Japanese encephalitis (JE) to people throughout Southeast Asia. In 2013, the JE vaccine became the first made in China to obtain World Health Organization prequalification, which allowed the vaccine to reach millions more children in poor countries.
It also marked China’s entrance into the global vaccine marketplace, which could significantly shift how vaccines are made, delivered, and priced for the developing world. PATH is now working with Chinese manufacturers on vaccines for polio, influenza, and rotavirus (the most severe form of childhood diarrhea).
Tuberculosis: China has among the world’s highest rates of TB and multidrug-resistant TB. Early diagnosis and treatment are critical to prevention and control, so PATH and our partners are helping Chinese government agencies test innovative diagnostic tools for the disease.
Woman’s Condom: To give women a new option for protection against both unintended pregnancy and sexually transmitted infections, PATH is working with Chinese partners to advance the Woman’s Condom, a new-generation female condom that studies have found to be more acceptable to users than earlier products.
Photo: Courtesy of Bill & Melinda Gates Foundation/Lou Linwei.
PATH's work on Japanese encephalitis helps millions get access to a lifesaving vaccine
Helping women take charge of their own protection
Ending tuberculosis with innovation in diagnosis, treatment, and prevention
An overview of our work in China